Scientific panel finds numerous flaws in FDA report on BPA
A scientific panel convened to review the FDA’s conclusion that BPA is not dangerous at current levels found substantial problems with the agency’s methods. While the panel did not address the fundamental question regarding BPA’s safety, it found numerous flaws in the FDA’s report, including that (via NYT’s Well):
The FDA assessment does not have an adequate number of infant formula samples and relies too heavily on averages, rather than accounting for variability in the samples.
The agency excluded several important animal studies that raised questions about the safety of BPA.
New research on BPA in adult humans and animals was published after the FDA’s draft report and should be included in its findings.
The margins of safety for BPA exposure used by the agency are “inadequate.”
The agency focused only on food-source exposures to BPA rather than the “totality of exposures” from other sources, which “severely limits the usefulness of the safety assessment.”
The panel included “environmental health, toxicology and statistics experts from three major universities, the Environmental Protection Agency and the Centers for Disease Control and Prevention.”
- Similar Posts:
- FDA claims BPA is safe for humans
- Canada set to declare chemical found in plastic ‘toxic.’
- Contradicting FDA, Researchers Find BPA Toxic to Humans at Typical Levels
Comments
Please contribute to the discussion by leaving a comment below. No need to agree with the post or other commenters, but please be constructive and respectful.
